1. Association between serum Caveolin-1 level and hemorrhagic transformation in patients with acute ischemic stroke after intravenous thrombolysis with alteplase
- Author
-
YANG Jiangsheng, ZHU Zufu, SHEN Liping, LU Rulan
- Subjects
caveolin 1 ,ischemic stroke ,tissue plasminogen activator ,thrombolytic therapy ,postoperative complications ,hemorrhagic transformation ,Medicine - Abstract
Objective To investigate the association between serum Caveolin-1 level and hemorrhagic transformation (HT) in patients with acute ischemic stroke (AIS) after intravenous thrombolysis with alteplase. Methods A total of 124 patients with AIS who underwent intravenous thrombolysis with alteplase in our hospital from June 2020 to November 2021 were enrolled as subjects, and according to the presence or absence of HT, they were divided into HT group with 19 patients and non-HT group with 105 patients. A total of 40 individuals who underwent physical examination during the same period of time were enrolled as control group. Serum Caveolin-1 level was measured and compared between groups, and the HT group and the non-HT group were compared in terms of the clinical indices including sex, age, body mass index, smoking history, hypertension history, diabetes history, coronary heart disease history, atrial fibrillation history, blood pressure on admission, random venous blood glucose on admission, serum low-density lipoprotein on admission, TOAST classification, and baseline NIHSS score. A logistic regression analysis was used to investigate the influencing factors for HT in AIS patients after intravenous thrombolysis with alteplase. Results The HT group and the non-HT group had a significantly higher serum level of Caveolin-1 than the control group on admission (t=10.937,7.873,P
- Published
- 2024
- Full Text
- View/download PDF